FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2005754580> ?p ?o ?g. }

• W2005754580 endingPage "1119" @default.
• W2005754580 startingPage "1111" @default.
• W2005754580 abstract "A single-center, double-blind, placebo-controlled, randomized study was conducted to determine the pharmacokinetics, safety, and tolerability of single, rising intramuscular (i.m.) doses and the single maximum tolerated dose of parecoxib sodium, a prodrug of the novel COX-2 selective anti-inflammatory analgesic drug valdecoxib, in 56 healthy male volunteers, ages 18 to 45 years inclusive. Cohorts of up to 6 subjects in each dose schedule were administered either parecoxib sodium (1 mg, 2 mg, 5 mg, 10 mg, 20 mg, or 40 mg) or matching placebo. Following i.m. administration, serial blood samples for measurement of plasma concentrations of parecoxib, valdecoxib, and valdecoxib metabolite (M1) were collected at predetermined intervals (from 15 minutes prior to dose and through 96 hours postdose). Urine collections were obtained for drug assay (from -12 to 0 hours, 0 to 12 hours, and 12 to 24 hours postdose). After i.m. administration, peak plasma concentrations of parecoxib were reached within 15 minutes and then declined rapidly as prodrug was converted to the active moiety, valdecoxib. Change in plasma concentrations of valdecoxib, which declined more slowly (t(1/2) = 5.4-9.9 hours), reflected transformation to several metabolites, one of which was the minor active metabolite M1. As measured by the AUC(0-infinity), Cmax, and XU(0-24) of valdecoxib, parecoxib sodium demonstrated dose proportionality when administered in the range of 1 mg to 40 mg of parecoxib. All single i.m. doses up to the maximum of 40 mg of parecoxib, as well as concentrations of up to 20 mg/ml, were well tolerated." @default.
• W2005754580 created "2016-06-24" @default.
• W2005754580 creator A5019287037 @default.
• W2005754580 creator A5023234261 @default.
• W2005754580 creator A5036550158 @default.
• W2005754580 creator A5038365482 @default.
• W2005754580 creator A5045035998 @default.
• W2005754580 creator A5063048473 @default.
• W2005754580 creator A5090370925 @default.
• W2005754580 date "2001-10-01" @default.
• W2005754580 modified "2023-10-02" @default.
• W2005754580 title "A Pharmacokinetic Study of Intramuscular (IM) Parecoxib Sodium in Normal Subjects" @default.
• W2005754580 cites W1972733540 @default.
• W2005754580 cites W1973788284 @default.
• W2005754580 cites W1976654542 @default.
• W2005754580 cites W1985813197 @default.
• W2005754580 cites W1997364548 @default.
• W2005754580 cites W2008574207 @default.
• W2005754580 cites W2034323095 @default.
• W2005754580 cites W2039358393 @default.
• W2005754580 cites W2078736915 @default.
• W2005754580 cites W2092193486 @default.
• W2005754580 cites W2149233326 @default.
• W2005754580 cites W2398006323 @default.
• W2005754580 cites W4292059951 @default.
• W2005754580 doi "https://doi.org/10.1177/00912700122012607" @default.
• W2005754580 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11583480" @default.
• W2005754580 hasPublicationYear "2001" @default.
• W2005754580 type Work @default.
• W2005754580 sameAs 2005754580 @default.
• W2005754580 citedByCount "64" @default.
• W2005754580 countsByYear W20057545802012 @default.
• W2005754580 countsByYear W20057545802013 @default.
• W2005754580 countsByYear W20057545802014 @default.
• W2005754580 countsByYear W20057545802015 @default.
• W2005754580 countsByYear W20057545802016 @default.
• W2005754580 countsByYear W20057545802017 @default.
• W2005754580 countsByYear W20057545802018 @default.
• W2005754580 countsByYear W20057545802019 @default.
• W2005754580 countsByYear W20057545802020 @default.
• W2005754580 crossrefType "journal-article" @default.
• W2005754580 hasAuthorship W2005754580A5019287037 @default.
• W2005754580 hasAuthorship W2005754580A5023234261 @default.
• W2005754580 hasAuthorship W2005754580A5036550158 @default.
• W2005754580 hasAuthorship W2005754580A5038365482 @default.
• W2005754580 hasAuthorship W2005754580A5045035998 @default.
• W2005754580 hasAuthorship W2005754580A5063048473 @default.
• W2005754580 hasAuthorship W2005754580A5090370925 @default.
• W2005754580 hasConcept C108215921 @default.
• W2005754580 hasConcept C112705442 @default.
• W2005754580 hasConcept C142724271 @default.
• W2005754580 hasConcept C149151106 @default.
• W2005754580 hasConcept C181199279 @default.
• W2005754580 hasConcept C185592680 @default.
• W2005754580 hasConcept C197934379 @default.
• W2005754580 hasConcept C204787440 @default.
• W2005754580 hasConcept C22979827 @default.
• W2005754580 hasConcept C27081682 @default.
• W2005754580 hasConcept C2776291583 @default.
• W2005754580 hasConcept C2778375690 @default.
• W2005754580 hasConcept C2778582115 @default.
• W2005754580 hasConcept C2779262571 @default.
• W2005754580 hasConcept C2779528491 @default.
• W2005754580 hasConcept C2779689624 @default.
• W2005754580 hasConcept C2780820201 @default.
• W2005754580 hasConcept C42219234 @default.
• W2005754580 hasConcept C55493867 @default.
• W2005754580 hasConcept C71924100 @default.
• W2005754580 hasConcept C87813604 @default.
• W2005754580 hasConcept C98274493 @default.
• W2005754580 hasConceptScore W2005754580C108215921 @default.
• W2005754580 hasConceptScore W2005754580C112705442 @default.
• W2005754580 hasConceptScore W2005754580C142724271 @default.
• W2005754580 hasConceptScore W2005754580C149151106 @default.
• W2005754580 hasConceptScore W2005754580C181199279 @default.
• W2005754580 hasConceptScore W2005754580C185592680 @default.
• W2005754580 hasConceptScore W2005754580C197934379 @default.
• W2005754580 hasConceptScore W2005754580C204787440 @default.
• W2005754580 hasConceptScore W2005754580C22979827 @default.
• W2005754580 hasConceptScore W2005754580C27081682 @default.
• W2005754580 hasConceptScore W2005754580C2776291583 @default.
• W2005754580 hasConceptScore W2005754580C2778375690 @default.
• W2005754580 hasConceptScore W2005754580C2778582115 @default.
• W2005754580 hasConceptScore W2005754580C2779262571 @default.
• W2005754580 hasConceptScore W2005754580C2779528491 @default.
• W2005754580 hasConceptScore W2005754580C2779689624 @default.
• W2005754580 hasConceptScore W2005754580C2780820201 @default.
• W2005754580 hasConceptScore W2005754580C42219234 @default.
• W2005754580 hasConceptScore W2005754580C55493867 @default.
• W2005754580 hasConceptScore W2005754580C71924100 @default.
• W2005754580 hasConceptScore W2005754580C87813604 @default.
• W2005754580 hasConceptScore W2005754580C98274493 @default.
• W2005754580 hasIssue "10" @default.
• W2005754580 hasLocation W20057545801 @default.
• W2005754580 hasLocation W20057545802 @default.
• W2005754580 hasOpenAccess W2005754580 @default.
• W2005754580 hasPrimaryLocation W20057545801 @default.
• W2005754580 hasRelatedWork W2005754580 @default.

• next